Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: A nationwide register study

Diabetic Medicine

Volumn 33, Issue 2, 2016, Pages 218-223

  Radholm K ^a   Wirehn A B ^a   Chalmers, J ^b   Ostgren C J ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE REGISTRY; DRUG USE; FATALITY; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RISK ASSESSMENT; SWEDEN; AGE; CHEMICALLY INDUCED; COMPARATIVE STUDY; COMPLICATION; DEPRESSION; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; FOLLOW UP; INCIDENCE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PSYCHOLOGY; REGISTER; RISK FACTOR; SEX DIFFERENCE; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; COHORT STUDIES; DEPRESSION; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHIES; DRUG PRESCRIPTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SEX FACTORS; SWEDEN;

EID: 84955341911     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12822     Document Type: Article

References (26)

1. World Health Organisation, The Top 10 Causes of Death. Available at http://who.int/mediacentre/factsheets/fs310/en/. Last accessed 5 June 2015.
2. Kengne AP, Turnbull F, MacMahon S. The Framingham Study, diabetes mellitus and cardiovascular disease: turning back the clock. Prog Cardiovasc Dis 2010; 53: 45-51.
3. Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA etal. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 953-962.
4. Patten SB, Williams JV, Lavorato DH, Modgill G, Jette N, Eliasziw M. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry 2008; 30: 407-413.
5. Garfield LD, Scherrer JF, Hauptman PJ, Freedland KE, Chrusciel T, Balasubramanian S etal. Association of Anxiety Disorders and Depression With Incident Heart Failure. Psychosom Med 2014; 76: 128-136.
6. Lustman PJ, Penckofer SM, Clouse RE. Recent advances in understanding depression in adults with diabetes. Curr Psychiatry Rep 2008; 10: 495-502.
7. Tovar E, Rayens MK, Gokun Y, Clark M. Mediators of adherence among adults with comorbid diabetes and depression: The role of self-efficacy and social support. J Health Psychol 2015; 20: 1405-1415.
8. Lustman PJ, Clouse RE, Nix BD, Freedland KE, Rubin EH, McGill JB etal. Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry 2006; 63: 521-529.
9. Williams MM, Clouse RE, Nix BD, Rubin EH, Sayuk GS, McGill JB etal. Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes. Diabetes Care 2007; 30: 801-806.
10. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000; 23: 934-942.
11. Holt RI, de Groot M, Lucki I, Hunter CM, Sartorius N, Golden SH. NIDDK international conference report on diabetes and depression: current understanding and future directions. Diabetes Care 2014; 37: 2067-2077.
12. Bryan C, Songer T, Brooks MM, Rush AJ, Thase ME, Gaynes B etal. The impact of diabetes on depression treatment outcomes. Gen Hosp Psychiatry 2010; 32: 33-41.
13. Lee WL, Cheung AM, Cape D, Zinman B. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care 2000; 23: 962-968.
14. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C etal. External review and validation of the Swedish national inpatient register. BMC Pub Health 2011; 11: 450.
15. The Swedish Prescribed Drug Register (National Board of Health and Welfare)Läkemedelsregistret (Socialstyrelsen), in Swedish. Available at http://www.socialstyrelsen.se/register/halsodataregister/lakemedelsregistret. Last accessed 5 June 2015.
16. Official Statistics of Sweden, Myocardial infarctions in Sweden 1987-2008 (in Swedish). Available at http://wwwsocialstyrelsense/statistics 2010. Last accessed 5 June 2015.
17. WHO Collaborating Centre for Drug Statistics Methodology, ATC, Structure and principles. Available at http://wwwwhoccno/atc/structure_and_principles/. Last accessed 5 June 2015.
18. Statistics Sweden, Population statistics. Available at http://www.scb.se/en_/Finding-statistics/Statistics-by-subject-area/Population/Population-composition/Population-statistics/. Last accessed 5 June 2015.
19. Scherrer JF, Garfield LD, Chrusciel T, Hauptman PJ, Carney RM, Freedland KE etal. Increased risk of myocardial infarction in depressed patients with type 2 diabetes. Diabetes Care 2011; 34: 1729-1734. Last accessed 05 June 2015.
20. Hofmann M, Kohler B, Leichsenring F, Kruse J. Depression as a risk factor for mortality in individuals with diabetes: a meta-analysis of prospective studies. PloS One 2013; 8: e79809.
21. Brown LC, Majumdar SR, Johnson JA. Type of antidepressant therapy and risk of type 2 diabetes in people with depression. Diabetes Res Clin Pract 2008; 79: 61-67.
22. Yoon JM, Cho EG, Lee HK, Park SM. Antidepressant use and diabetes mellitus risk: a meta-analysis. Kor J Fam Med 2013; 34: 228-240.
23. Bhattacharjee S, Bhattacharya R, Kelley GA, Sambamoorthi U. Antidepressant use and new-onset diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev 2013; 29: 273-284.
24. Lustman PJ, Freedland KE, Griffith LS, Clouse RE. Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 2000; 23: 618-623.
25. Knol MJ, Derijks HJ, Geerlings MI, Heerdink ER, Souverein PC, Gorter KJ etal. Influence of antidepressants on glycaemic control in patients with diabetes mellitus. Pharmacoepidemiol Drug Saf 2008; 17: 577-586.
26. Wirehn AB, Karlsson HM, Carstensen JM. Estimating disease prevalence using a population-based administrative healthcare database. Scand J Pub Health 2007; 35: 424-431.